Clinical Trials Logo
  1. Home
  2. Pituitary Diseases
  3. NCT00473369
  4. Details
NCT00473369 Clinical Trial

Prognosis of Atypical Pituitary Adenomas

Pituitary Diseases Clinical Trial

Clinical Trial Details — Status: Active, not recruiting

Administrative data
NCT number NCT00473369
Other study ID # 1-2007.nsg.med.tohoku
Secondary ID
Status Active, not recruiting
Phase N/A
First received May 14, 2007
Last updated May 14, 2007
Start date January 2001
Est. completion date May 2007

Study information
Verified date May 2007
Source Tohoku University
Contact n/a
Is FDA regulated No
Health authority Japan: Institutional Review Board
Study type Observational

Clinical Trial Summary

Context: Pituitary adenoma is generally indolent, but an aggressive subtype called atypical adenoma has uncertain prognosis, and an unclear relationship between prognosis and morphology.

Objective: This study investigated the prognostic factors of this tumor. Design: Retrospective analysis. Setting: University and associated hospitals.

Recruitment information / eligibility
Status Active, not recruiting
Enrollment 0
Est. completion date May 2007
Est. primary completion date
Accepts healthy volunteers
Gender Both
Age group 12 Years to 74 Years
Eligibility Inclusion Criteria:

- pituitary adenomas of more than 3 % of Ki67 labeling index surgically treated at Tohoku university and associated hospital

Exclusion Criteria:

- pituitary adenomas of less than 3 % of Ki-67 labeling index surgically treated at Tohoku university and associated hospital

Study Design

Observational Model: Case Control, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Tohoku University
See also
  Status Clinical Trial Phase
Recruiting NCT04897802 - Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study) Phase 4
Completed NCT03137615 - The Cardiovascular Changes Associated With Septal Local Anaesthesia N/A
Completed NCT03305016 - A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency Phase 3
Completed NCT02084134 - Peri-Operative Steroid Management in Patients N/A
Completed NCT00234533 - Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq Phase 3
Completed NCT04902235 - Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study) Phase 4
Recruiting NCT04951557 - Setting Benchmarks for Transsphenoidal Resection of Pituitary Adenomas
Recruiting NCT06435195 - Clinical Characteristics and Analysis of Pituitary Complex and Rare Diseases
Active, not recruiting NCT03665064 - Long Term Outcome Study in Patients With Pituitary Disorders
Completed NCT02782208 - Lipolytic Effects of GH in Hypopituitary Patients in Vivo N/A
Recruiting NCT04326374 - Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Chinese Pediatric Growth Hormone Deficiency Phase 3
Completed NCT03344458 - A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial Phase 3
Completed NCT02781727 - A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD) Phase 3